Legend Biotech Corp Overview
Legend Biotech Corp Target Price
Analysts' 12-month price predictions for LEGN.
Share Price
$36.29
Average Target Price
$75.00
106.7% upside
106.7% upside1 analysts in the last 4 months
High: $75 | Low: $75
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2025-03-12 | H.C. WainwrightMitchell Kapoor | $75 | 106.7% upside |  |
| 2024-11-13 | Cantor FitzgeraldRick Bienkowski | $83 | 128.7% upside | |
| 2024-10-15 | BTIGJustin Zelin | $91 | 150.8% upside | |
| 2024-10-15 | Johnson RiceGena Wang | $94 | 159% upside | |
| 2024-10-15 | BarclaysGena Wang | $94 | 159% upside | |
| 2024-10-08 | Redburn PartnersQize Ding | $86 | 137% upside | |
| 2024-06-17 | Piper SandlerEdward Tenthoff | $90 | 148% upside | |
| 2024-06-17 | Truist FinancialAsthika Goonewardene | $88 | 142.5% upside | |
| 2024-05-23 | Deutsche BankJames Shin | $60 | 65.3% upside | |
| 2024-05-17 | Morgan StanleyMatthew Harrison | $82 | 126% upside | |
| 2024-05-14 | RBC CapitalLeonid Timashev | $86 | 137% upside | |
| 2024-04-17 | ScotiabankGeorge Farmer | $65 | 79.1% upside | |
| 2024-04-03 | Cantor FitzgeraldRick Bienkowski | $82 | 126% upside | |
| 2024-03-14 | BMO CapitalKostas Biliouris | $90 | 148% upside | |
| 2022-12-06 | UBS | $66 | 81.9% upside | |